Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1

Only palliative therapeutic options exist for the treatment of Alzheimer’s Disease; no new successful drug candidates have been developed in over 15 years. The widely used clinical anticoagulant heparin has been reported to exert beneficial effects through multiple pathophysiological pathways involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mycroft-West, Courtney J., Devlin, Anthony J., Cooper, Lynsay C., Guimond, Scott E., Procter, Patricia, Guerrini, Marco, Miller, Gavin J., Fernig, David G., Yates, Edwin A., Lima, Marcelo A., Skidmore, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067017/
https://www.ncbi.nlm.nih.gov/pubmed/33916819
http://dx.doi.org/10.3390/md19040203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067017/
https://www.ncbi.nlm.nih.gov/pubmed/33916819
http://dx.doi.org/10.3390/md19040203

Ejemplares similares